Liu et al. (2018) demonstrated that the panel containing programmed cell death protein 1 (PD-1), interleukin-10 (IL-10), interleukin-2 receptor alpha (IL-2Rα) and CA15-3 can discriminate BC from benign breast disease. Here, IL2RA is linked to breast cancer.